Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status betwee...
Saved in:
Published in | Journal of hematology and oncology Vol. 12; no. 1; pp. 140 - 12 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
21.12.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017.
We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study.
In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose.
The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. |
---|---|
AbstractList | Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Keywords: Breast cancer, Global cancer burden, Disability-adjusted life years, Alcohol use, Incidence Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017.BACKGROUNDStatistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017.We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study.METHODSWe extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study.In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose.RESULTSIn 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose.The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.CONCLUSIONThe increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Abstract Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. |
ArticleNumber | 140 |
Audience | Academic |
Author | Zhai, Zhen Zheng, Yi Li, Na Deng, Yujiao Hao, Qian Yang, Si Zhang, Dai Tian, Tian Kang, Huafeng Dai, Zhijun Wu, Ying Zhou, Linghui Song, Dingli |
Author_xml | – sequence: 1 givenname: Na surname: Li fullname: Li, Na – sequence: 2 givenname: Yujiao surname: Deng fullname: Deng, Yujiao – sequence: 3 givenname: Linghui surname: Zhou fullname: Zhou, Linghui – sequence: 4 givenname: Tian surname: Tian fullname: Tian, Tian – sequence: 5 givenname: Si surname: Yang fullname: Yang, Si – sequence: 6 givenname: Ying surname: Wu fullname: Wu, Ying – sequence: 7 givenname: Yi surname: Zheng fullname: Zheng, Yi – sequence: 8 givenname: Zhen surname: Zhai fullname: Zhai, Zhen – sequence: 9 givenname: Qian surname: Hao fullname: Hao, Qian – sequence: 10 givenname: Dingli surname: Song fullname: Song, Dingli – sequence: 11 givenname: Dai surname: Zhang fullname: Zhang, Dai – sequence: 12 givenname: Huafeng surname: Kang fullname: Kang, Huafeng – sequence: 13 givenname: Zhijun orcidid: 0000-0001-5209-8626 surname: Dai fullname: Dai, Zhijun |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31864424$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1u1DAUhSNURNuBB2CDLCEhFqTYjmPHLJBKgVKpEgtgbdnO9YxLJm5tB6kvxHPi-WmZqUBZOPb9zvHNzTmuDsYwQlU9J_iEkI6_TaTBrK0xkTXuaFfjR9URES2vO0Hpwc77YXWc0hXGnEiKn1SHTVEzRtlR9ft8CEYPyEyxhxEFh0wEnTKyerQQkR57pHOO3kxZmwFQ9OknctrmEBPyIyKyRTZMY0EgrfEMMfpSLvs3yMWwLIzEKAdEMRHvUIQ0DTltSnkBaNvCh_sWPvpUegD0LU_97Vr1tHrs9JDg2XadVT8-f_p-9qW-_Hp-cXZ6WdtWklxz2xECxvXclFUaLo3DopOibcA5YwUF1wrRi54B7UjZEgnSdSBFwzSDZlZdbHz7oK_UdfRLHW9V0F6tD0KcKx2ztwMoLbXoNGl7IYBZy3XHuQHQjLSmY5YWr_cbr-vJLKG3UGakhz3T_croF2oefikuactKR7Pq9dYghpsJUlZLnywMgx4hTEnRpim_lGLJC_ryAXoVpjiWURWKYcEx79hfaq7LB_jRhXKvXZmqU05wQxkTTaFO_kGVp4eltyWBzpfzPcGrHcEC9JAXKQxT9mFM--CL3Yncj-IujgUQG8DGkFIEp6zPeuVTWvCDIlitgq82wVcl-GoVfIWLkjxQ3pn_X_MHo1oCkA |
CitedBy_id | crossref_primary_10_1177_10732748251328413 crossref_primary_10_1038_s41598_024_54762_x crossref_primary_10_4274_balkanmedj_galenos_2024_2024_4_91 crossref_primary_10_4103_abr_abr_200_22 crossref_primary_10_3389_fmolb_2022_856064 crossref_primary_10_1186_s12885_021_08217_5 crossref_primary_10_1186_s40364_021_00310_y crossref_primary_10_3389_fonc_2022_836126 crossref_primary_10_1002_jcla_23720 crossref_primary_10_1134_S0026893321020163 crossref_primary_10_1136_bmjopen_2022_071306 crossref_primary_10_1038_s41598_021_87209_8 crossref_primary_10_1038_s41598_024_61600_7 crossref_primary_10_1186_s13045_020_00908_z crossref_primary_10_3389_fonc_2022_853038 crossref_primary_10_3389_fmolb_2021_675198 crossref_primary_10_1016_j_intimp_2020_106756 crossref_primary_10_1186_s13058_023_01609_4 crossref_primary_10_1007_s00520_021_06692_x crossref_primary_10_2147_IJGM_S447201 crossref_primary_10_1186_s12935_023_02860_7 crossref_primary_10_1186_s13045_020_00981_4 crossref_primary_10_1186_s13045_021_01052_y crossref_primary_10_1080_07853890_2024_2314235 crossref_primary_10_1097_CM9_0000000000001814 crossref_primary_10_3390_molecules28124876 crossref_primary_10_1111_ahg_12415 crossref_primary_10_2147_CLEP_S388323 crossref_primary_10_1016_j_jare_2022_10_007 crossref_primary_10_3389_fonc_2022_1010088 crossref_primary_10_18632_aging_202415 crossref_primary_10_3390_cancers12092419 crossref_primary_10_1016_j_eclinm_2024_102713 crossref_primary_10_1136_bmjopen_2022_066505 crossref_primary_10_1186_s12885_023_10962_8 crossref_primary_10_1016_j_maturitas_2021_06_008 crossref_primary_10_18632_aging_203187 crossref_primary_10_2147_CMAR_S274204 crossref_primary_10_1002_cam4_3305 crossref_primary_10_1186_s12889_023_17405_w crossref_primary_10_1016_j_biopha_2020_111139 crossref_primary_10_1002_jmv_28768 crossref_primary_10_3389_fnut_2022_817836 crossref_primary_10_3390_ijerph20010840 crossref_primary_10_1002_cam4_5166 crossref_primary_10_1007_s12282_021_01267_4 crossref_primary_10_1186_s40164_020_00181_3 crossref_primary_10_20892_j_issn_2095_3941_2022_0231 crossref_primary_10_1007_s11356_022_24410_w crossref_primary_10_2147_IJGM_S319801 crossref_primary_10_3390_ijerph191610068 crossref_primary_10_3389_fnut_2022_847920 crossref_primary_10_1038_s41598_024_84115_7 crossref_primary_10_1007_s10549_020_05736_w crossref_primary_10_18857_jkpt_2020_32_3_176 crossref_primary_10_3389_fpubh_2022_1078191 crossref_primary_10_1038_s41597_023_02253_5 crossref_primary_10_1016_j_prp_2020_153131 crossref_primary_10_1186_s12885_024_12796_4 crossref_primary_10_24018_ejbiomed_2022_1_4_20 crossref_primary_10_1039_D0DT00507J crossref_primary_10_1002_ctm2_400 crossref_primary_10_3389_fpubh_2024_1371253 crossref_primary_10_1016_j_semcancer_2020_08_009 crossref_primary_10_1136_bmjopen_2021_052676 crossref_primary_10_1016_j_clbc_2023_04_009 crossref_primary_10_1186_s13058_023_01633_4 crossref_primary_10_3390_metabo12040350 crossref_primary_10_1017_S1368980022001987 crossref_primary_10_3390_ijms24021168 crossref_primary_10_1093_jnci_djad101 crossref_primary_10_1016_j_jare_2021_07_012 crossref_primary_10_2147_CMAR_S280009 crossref_primary_10_3390_nu16060800 crossref_primary_10_1093_pubmed_fdaa099 crossref_primary_10_1016_j_clon_2022_05_007 crossref_primary_10_1097_CM9_0000000000001347 crossref_primary_10_3390_nu12020512 crossref_primary_10_1186_s12964_024_01487_z crossref_primary_10_1002_jcla_24186 crossref_primary_10_3389_fonc_2020_01245 crossref_primary_10_3389_fonc_2022_998641 crossref_primary_10_1097_CEJ_0000000000000909 crossref_primary_10_1111_cbdd_14222 crossref_primary_10_2147_JIR_S376248 crossref_primary_10_1038_s41523_021_00293_x crossref_primary_10_1007_s00432_025_06113_0 crossref_primary_10_1007_s10528_021_10029_y crossref_primary_10_1038_s41388_020_01574_8 crossref_primary_10_51847_KBUc8DsiTj crossref_primary_10_1007_s00432_023_05380_z crossref_primary_10_1186_s13053_020_00159_6 crossref_primary_10_3389_fonc_2022_905846 crossref_primary_10_1080_2162402X_2020_1859731 crossref_primary_10_1002_iub_2764 crossref_primary_10_1007_s12553_021_00592_0 crossref_primary_10_1111_papr_13009 crossref_primary_10_1186_s12982_025_00491_z crossref_primary_10_1002_cam4_5006 crossref_primary_10_1186_s12916_023_02950_3 crossref_primary_10_1016_j_imu_2022_101009 crossref_primary_10_2196_49197 crossref_primary_10_1136_bmjopen_2020_044283 crossref_primary_10_1002_jgm_3271 crossref_primary_10_1186_s13000_022_01249_w crossref_primary_10_1016_j_prp_2020_153117 crossref_primary_10_1093_ehjqcco_qcae049 crossref_primary_10_18632_aging_202502 crossref_primary_10_1016_j_bioorg_2021_105017 crossref_primary_10_1177_15347354221104092 crossref_primary_10_46234_ccdcw2023_065 crossref_primary_10_3389_fonc_2021_642768 crossref_primary_10_4103_cjop_CJOP_D_22_00165 crossref_primary_10_1016_j_eclinm_2021_100986 crossref_primary_10_1186_s12889_024_19934_4 crossref_primary_10_18632_aging_103881 crossref_primary_10_3389_fonc_2021_689562 crossref_primary_10_1016_j_jcjd_2023_12_007 crossref_primary_10_2147_IJN_S460712 crossref_primary_10_1039_D3FO04279K crossref_primary_10_1186_s13045_021_01213_z crossref_primary_10_1002_gcc_23150 crossref_primary_10_1007_s12262_020_02388_4 crossref_primary_10_1016_j_heliyon_2024_e33639 crossref_primary_10_2147_IJN_S321071 crossref_primary_10_1111_1759_7714_15316 crossref_primary_10_1038_s41420_021_00693_9 crossref_primary_10_1002_mop_32962 crossref_primary_10_1016_j_puhe_2024_01_008 crossref_primary_10_12677_acm_2024_1472054 crossref_primary_10_1111_cbdd_13963 crossref_primary_10_3390_biology10070566 crossref_primary_10_1016_j_apmr_2023_07_005 crossref_primary_10_3389_fonc_2024_1359839 crossref_primary_10_1590_s2237_96222022000300021 crossref_primary_10_1007_s11356_023_29579_2 crossref_primary_10_3389_fpubh_2023_1282451 crossref_primary_10_1186_s13690_022_00918_y crossref_primary_10_1186_s12966_022_01283_3 crossref_primary_10_1007_s00432_021_03651_1 crossref_primary_10_3389_fepid_2023_1122790 crossref_primary_10_3389_fonc_2021_612009 crossref_primary_10_1038_s41568_020_0266_x crossref_primary_10_1097_CEJ_0000000000000915 crossref_primary_10_1136_bmjopen_2021_051808 crossref_primary_10_1186_s40164_022_00361_3 crossref_primary_10_3389_fonc_2022_819531 crossref_primary_10_1186_s13550_024_01115_4 crossref_primary_10_7189_jogh_14_04142 crossref_primary_10_1038_s41598_024_65821_8 crossref_primary_10_3389_fonc_2024_1415762 crossref_primary_10_1177_0300060520973137 crossref_primary_10_3390_cancers17020197 crossref_primary_10_1016_j_clbc_2022_02_011 crossref_primary_10_1016_j_rxeng_2021_04_003 crossref_primary_10_1590_1414_462x202533010371 crossref_primary_10_1200_GO_21_00288 crossref_primary_10_1155_2021_9025481 crossref_primary_10_2147_CMAR_S268725 crossref_primary_10_3389_fphys_2023_1042603 crossref_primary_10_1155_2021_6610511 crossref_primary_10_1016_j_ssmph_2023_101418 crossref_primary_10_1155_2022_6168832 crossref_primary_10_3389_fpubh_2021_619581 crossref_primary_10_3390_jcm13071937 crossref_primary_10_1136_bmjopen_2021_050387 crossref_primary_10_1177_10732748221115469 crossref_primary_10_1016_j_injury_2024_111955 crossref_primary_10_1007_s12094_021_02587_9 crossref_primary_10_2147_BCTT_S366530 crossref_primary_10_18632_aging_203472 crossref_primary_10_1111_jog_15931 crossref_primary_10_1097_MD_0000000000023461 crossref_primary_10_3892_etm_2021_9699 crossref_primary_10_1002_cam4_3793 crossref_primary_10_3390_healthcare10091611 crossref_primary_10_1186_s12943_020_1145_5 crossref_primary_10_1016_j_bioorg_2023_106437 crossref_primary_10_18632_aging_203686 crossref_primary_10_3390_ijerph19095399 crossref_primary_10_1016_j_eclinm_2024_103027 crossref_primary_10_1186_s40164_020_00170_6 crossref_primary_10_1002_jcla_23365 crossref_primary_10_3389_fmed_2021_667543 crossref_primary_10_1007_s11356_021_14165_1 crossref_primary_10_1016_j_rx_2021_04_003 crossref_primary_10_1186_s13045_020_00915_0 crossref_primary_10_1080_14737167_2021_1947247 crossref_primary_10_3389_fonc_2021_779185 crossref_primary_10_1186_s12916_024_03772_7 crossref_primary_10_3389_fgene_2020_634195 crossref_primary_10_1177_17588359211009003 crossref_primary_10_1631_jzus_B1900709 crossref_primary_10_1016_j_gaceta_2021_07_011 crossref_primary_10_1016_j_intimp_2020_106797 crossref_primary_10_1002_jcp_29755 crossref_primary_10_1002_cnr2_1827 crossref_primary_10_1136_bmjopen_2022_064417 crossref_primary_10_1007_s11033_020_05823_7 crossref_primary_10_1021_acs_jproteome_1c00075 crossref_primary_10_29333_ejosdr_16054 crossref_primary_10_2147_CMAR_S266575 crossref_primary_10_1016_j_isci_2024_111045 crossref_primary_10_1186_s40164_020_00169_z crossref_primary_10_1186_s12889_024_18023_w crossref_primary_10_1016_j_cmet_2021_08_005 crossref_primary_10_12968_ijpn_2023_29_4_159 crossref_primary_10_3390_cancers13122922 crossref_primary_10_1186_s42506_021_00073_2 crossref_primary_10_3389_ijph_2021_603810 crossref_primary_10_1016_j_envint_2021_106725 crossref_primary_10_1259_bjr_20200038 crossref_primary_10_3389_fpubh_2023_1137286 crossref_primary_10_1007_s00432_023_05159_2 crossref_primary_10_1039_D0CC05422D crossref_primary_10_1007_s10549_022_06543_1 crossref_primary_10_1016_j_senol_2020_12_005 crossref_primary_10_2147_BCTT_S447933 crossref_primary_10_1038_s41746_022_00559_z crossref_primary_10_1016_j_anr_2023_11_002 crossref_primary_10_1016_j_bioorg_2024_107496 crossref_primary_10_1158_1055_9965_EPI_23_1034 crossref_primary_10_1186_s12890_022_01944_w crossref_primary_10_3390_healthcare9070907 crossref_primary_10_1016_j_jpba_2021_114134 crossref_primary_10_1007_s12033_022_00524_x crossref_primary_10_3390_nu15245131 crossref_primary_10_1007_s10815_023_02939_0 crossref_primary_10_1016_j_focha_2023_100453 crossref_primary_10_3389_fonc_2020_00650 crossref_primary_10_1016_j_ecoenv_2022_113551 crossref_primary_10_1016_j_ssmqr_2022_100135 crossref_primary_10_1158_1940_6207_CAPR_20_0369 |
Cites_doi | 10.1093/alcalc/ags011 10.1371/journal.pone.0178928 10.1016/S0140-6736(18)32279-7 10.2991/j.jegh.2018.09.003 10.1186/s13045-019-0799-1 10.1056/NEJMra1707939 10.1001/jamaoncol.2016.5688 10.1016/j.jhep.2015.07.032 10.1016/S0140-6736(16)31392-7 10.1016/S1470-2045(18)30447-9 10.1079/PHN2001294 10.1016/j.breast.2012.08.005 10.1007/s10654-011-9636-8 10.1016/S0140-6736(17)32154-2 10.1023/A:1008953201688 10.3390/cancers10100349 10.1186/1478-7954-10-1 10.1677/ERC-06-0068 10.1001/jamaoncol.2018.2706 10.1016/j.ejca.2018.08.024 10.1097/00001648-199909000-00029 10.1371/journal.pone.0039507 10.1186/s13045-019-0783-9 10.1016/S0140-6736(17)31833-0 10.1200/EDBK_201315 10.1158/1055-9965.1558.13.10 10.1007/978-3-319-09614-8_2 10.2105/AJPH.2012.300913 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s13045-019-0828-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts ProQuest Central Health & Medical Collection (via ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1756-8722 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_a9a78a15d77e4cc6a866beea415b84c2 PMC6925497 A610324473 31864424 10_1186_s13045_019_0828_0 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom Western Europe United States--US North America China India South Asia |
GeographicLocations_xml | – name: United Kingdom – name: Western Europe – name: South Asia – name: China – name: United States--US – name: North America – name: India |
GrantInformation_xml | – fundername: ; grantid: No. 81471670 – fundername: ; grantid: (2017ZDXM-SF-066 |
GroupedDBID | --- 0R~ 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c591t-6c811ebfd6b11e9b69bf0789753effbc72ef577d7d4e28172e19e9f8e9734a4e3 |
IEDL.DBID | M48 |
ISSN | 1756-8722 |
IngestDate | Wed Aug 27 01:27:42 EDT 2025 Thu Aug 21 14:35:47 EDT 2025 Fri Jul 11 11:38:42 EDT 2025 Fri Jul 25 07:52:42 EDT 2025 Tue Jun 17 21:12:50 EDT 2025 Tue Jun 10 20:50:10 EDT 2025 Thu May 22 21:22:21 EDT 2025 Mon Jul 21 06:03:34 EDT 2025 Tue Jul 01 04:23:14 EDT 2025 Thu Apr 24 22:57:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Breast cancer Disability-adjusted life years Global cancer burden Alcohol use Incidence |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c591t-6c811ebfd6b11e9b69bf0789753effbc72ef577d7d4e28172e19e9f8e9734a4e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5209-8626 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13045-019-0828-0 |
PMID | 31864424 |
PQID | 2340760684 |
PQPubID | 54946 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a9a78a15d77e4cc6a866beea415b84c2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6925497 proquest_miscellaneous_2330062096 proquest_journals_2340760684 gale_infotracmisc_A610324473 gale_infotracacademiconefile_A610324473 gale_healthsolutions_A610324473 pubmed_primary_31864424 crossref_citationtrail_10_1186_s13045_019_0828_0 crossref_primary_10_1186_s13045_019_0828_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-12-21 |
PublicationDateYYYYMMDD | 2019-12-21 |
PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-21 day: 21 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of hematology and oncology |
PublicationTitleAlternate | J Hematol Oncol |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | M Begum (828_CR9) 2018; 104 CJ Murray (828_CR14) 1999; 10 Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016 (828_CR12) 2017; 390 Collaboration GBoDC (828_CR3) 2018; 4 BF Hankey (828_CR17) 2000; 11 Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017 (828_CR1) 2018; 392 N Mori (828_CR25) 2012; 102 L Vona-Davis (828_CR29) 2007; 14 KJ Foreman (828_CR11) 2012; 10 SH Giordano (828_CR2) 2018; 378 The burden of cancers and their variations across the states of India (828_CR7) 2018; 19 E Cazap (828_CR8) 2018; 38 H Sung (828_CR22) 2019; 69 MJ Hashim (828_CR6) 2018; 8 Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016 (828_CR10) 2017; 390 L Lin (828_CR4) 2019; 12 GY Hung (828_CR15) 2015; 63 O Ginsburg (828_CR5) 2017; 389 MJ Lee (828_CR24) 2002; 5 828_CR20 FP Turkoz (828_CR27) 2013; 22 Collaboration GBoDC (828_CR18) 2017; 3 L Zhou (828_CR13) 2019; 12 A Aitsi-Selmi (828_CR26) 2012; 7 S Gao (828_CR16) 2012; 27 HK Seitz (828_CR21) 2012; 47 S Zakhari (828_CR19) 2015; 815 MD Althuis (828_CR28) 2004; 13 Mohd Masood (828_CR23) 2017; 12 |
References_xml | – volume: 47 start-page: 204 year: 2012 ident: 828_CR21 publication-title: Alcohol and alcoholism (Oxford, Oxfordshire) doi: 10.1093/alcalc/ags011 – volume: 12 start-page: e0178928 issue: 6 year: 2017 ident: 828_CR23 publication-title: PLOS ONE doi: 10.1371/journal.pone.0178928 – volume: 392 start-page: 1789 year: 2018 ident: 828_CR1 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(18)32279-7 – volume: 8 start-page: 54 year: 2018 ident: 828_CR6 publication-title: J Epidemiol Glob Health. doi: 10.2991/j.jegh.2018.09.003 – volume: 12 start-page: 107 year: 2019 ident: 828_CR13 publication-title: Journal of hematology & oncology doi: 10.1186/s13045-019-0799-1 – volume: 378 start-page: 2311 year: 2018 ident: 828_CR2 publication-title: New England Journal of Medicine. doi: 10.1056/NEJMra1707939 – volume: 3 start-page: 524 year: 2017 ident: 828_CR18 publication-title: JAMA oncology. doi: 10.1001/jamaoncol.2016.5688 – volume: 63 start-page: 1390 year: 2015 ident: 828_CR15 publication-title: Journal of hepatology. doi: 10.1016/j.jhep.2015.07.032 – volume: 389 start-page: 847 year: 2017 ident: 828_CR5 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(16)31392-7 – volume: 19 start-page: 1289 year: 2018 ident: 828_CR7 publication-title: The Lancet. Oncology doi: 10.1016/S1470-2045(18)30447-9 – volume: 5 start-page: 197 year: 2002 ident: 828_CR24 publication-title: Public health nutrition. doi: 10.1079/PHN2001294 – volume: 22 start-page: 344 year: 2013 ident: 828_CR27 publication-title: Breast (Edinburgh, Scotland) doi: 10.1016/j.breast.2012.08.005 – volume: 27 start-page: 39 year: 2012 ident: 828_CR16 publication-title: Eur J Epidemiol doi: 10.1007/s10654-011-9636-8 – volume: 390 start-page: 1211 year: 2017 ident: 828_CR10 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(17)32154-2 – volume: 11 start-page: 31 year: 2000 ident: 828_CR17 publication-title: Cancer causes & control : CCC. doi: 10.1023/A:1008953201688 – ident: 828_CR20 doi: 10.3390/cancers10100349 – volume: 69 start-page: 88 year: 2019 ident: 828_CR22 publication-title: CA: a cancer journal for clinicians – volume: 10 start-page: 1 year: 2012 ident: 828_CR11 publication-title: Popul Health Metr doi: 10.1186/1478-7954-10-1 – volume: 14 start-page: 189 year: 2007 ident: 828_CR29 publication-title: Endocrine-related cancer doi: 10.1677/ERC-06-0068 – volume: 4 start-page: 1553 year: 2018 ident: 828_CR3 publication-title: JAMA oncology. doi: 10.1001/jamaoncol.2018.2706 – volume: 104 start-page: 127 year: 2018 ident: 828_CR9 publication-title: European journal of cancer (Oxford, England : 1990) doi: 10.1016/j.ejca.2018.08.024 – volume: 10 start-page: 594 year: 1999 ident: 828_CR14 publication-title: Epidemiology (Cambridge, Mass.) doi: 10.1097/00001648-199909000-00029 – volume: 7 year: 2012 ident: 828_CR26 publication-title: PLoS One doi: 10.1371/journal.pone.0039507 – volume: 12 start-page: 96 year: 2019 ident: 828_CR4 publication-title: J Hematol Oncol doi: 10.1186/s13045-019-0783-9 – volume: 390 start-page: 1084 year: 2017 ident: 828_CR12 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(17)31833-0 – volume: 38 start-page: 451 year: 2018 ident: 828_CR8 publication-title: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting doi: 10.1200/EDBK_201315 – volume: 13 start-page: 1558 year: 2004 ident: 828_CR28 publication-title: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology doi: 10.1158/1055-9965.1558.13.10 – volume: 815 start-page: 7 year: 2015 ident: 828_CR19 publication-title: Advances in experimental medicine and biology doi: 10.1007/978-3-319-09614-8_2 – volume: 102 start-page: 2068 year: 2012 ident: 828_CR25 publication-title: American journal of public health doi: 10.2105/AJPH.2012.300913 |
SSID | ssj0061920 |
Score | 2.619355 |
Snippet | Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate... Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to... Abstract Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 140 |
SubjectTerms | Adolescent Adult Age Age Factors Aged Alcohol use Body mass index Breast cancer Breast Neoplasms - etiology Breast Neoplasms - mortality Breast Neoplasms, Male - etiology Breast Neoplasms, Male - mortality Cancer prevention Cancer research Comparative analysis Confidence intervals Disabilities Disability-adjusted life years Disease Drinking (Alcoholic beverages) Fasting Female Follow-Up Studies Gender Global Burden of Disease Global cancer burden Global Health Glucose Health risk assessment Hematology High income Humans Incidence Male Middle Aged Mortality Oncology Prevalence Prognosis Quality-Adjusted Life Years Risk assessment Risk Factors Studies Survival Rate Time Factors Trends United Kingdom Western Europe Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ (Directory of Open Access Journals) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dNYIgiM12utN5eNtVl0VYTy7sLSSZCi4sPbLTc_AP-TutSnqaaQS9eGqYVJpMqlKPTtVXjL0xFs0QKKhliqqW6DPXwfi-juhah7aJvQ9UKHz-VZ1dyC-X_eVeqy_KCSvwwGXjjrz12njRr7QGGaPyBl8C4NHwBCNj1r5o83bBVNHBFBXs7jCFUUcbQReCGDbbmiDb6mZhhTJY_58qec8mLfMl9wzQ6T12d_Ic-XFZ8X12C4YH7Pb5dDf-kP0q8P085MIEvk48UML5yCMx9ob7YcX9WBpcUb0Up6xyPvXb4VcDF7bnuXUERc-ZfCTYRkIRgc17ToUoSGMbPq45GnT9gWOovr0eN2UIPUk-LeFkXsKncv_DKV3xZ571iF2cfv728ayeujDUsbdirFU0QkBIKxXwaYOyIRFGPcY5kFKIuoXUa73SKwmtQX8IhAWbDFjdSS-he8wOhvUATxk3GB01kSD1Q5IidLYBb2Kfogg66QYq1uy44uIEUU6dMq5dDlWMcoWRDhnpiJGuqdi7ecqPgs_xN-ITYvVMSNDa-QcUODcJnPuXwFXsFQmKK3Wqs4Jwx4qwCaXUXcXeZgpSEbj86KdKB9wEAttaUB4uKPFox-XwThjdpFo2ru0k3aYqIyv2eh6mmZQuN8B6SzQdFcdieFqxJ0V25z-NShx94BZn64VUL3ZlOTJcfc_A48rS5wT97H9s43N2p6XzKNq6FYfsYLzZwgv078bwMh_l34jaTB0 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central Health & Medical Collection (via ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6gngRv62uGkEQxLBNm-bDi-yqyyKsJxfeLSRpqgtLu77Xd_Af8u90Js2rW4Q9FZoJpJ3JZCYz8xtC3mgDx1CUkYkuSCbAZmZeu4YFMK19VYbGeSwUPv0mT87E11Wzyhdum5xWudOJSVG3Q8A78oOqFhhEklp8vPzFsGsURldzC42b5BZCl2FKl1rNDhf6BrtIJtfyYMMxLAjOs2EI3MbKxVmUIPv_V8xXTqZl1uSVY-j4Hrmb7Ud6ODH8PrkR-wfk9mmOkD8kfyYQf-pTeQIdOuox7XykAdm7pq5vqRunNldYNUUxt5zmrjv0vKfwgTQ1kEAfOpGPCN6IWCJx855iOQrQmJKOA4VjXX2g4LBvL8bNNAT2JM1LOJqX8HmKAlFMWvydZj0iZ8dfvn86YbkXAwuN4SOTQXMefddKD0_jpfEdItWDtxO7zgdVxa5RqlWtiJUGqyhyE02no1G1cCLWj8leP_TxKaEafKQyILC-7wT3tSmj06HpAveqU2UsSLnjig0ZqBz7ZVzY5LBoaSdGWmCkRUbasiDv5imXE0rHdcRHyOqZEAG204th_cPm_WqdcUo73rRKRRGCdBpkN0YH9o7XIlQFeYWCYqdq1VlN2EOJCIVCqLogbxMFKgpYfnC53gF-AkJuLSj3F5SwwcNyeCeMNiuYjf23HQryeh7GmZg018dhizQ1lsiCk1qQJ5Pszh8Nqhws4Qpmq4VUL_7KcqQ__5ngx6XBSwX17PplPSd3KtxpvGIV3yd743obX4D9NvqXaZP-BWyWQro priority: 102 providerName: ProQuest |
Title | Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31864424 https://www.proquest.com/docview/2340760684 https://www.proquest.com/docview/2330062096 https://pubmed.ncbi.nlm.nih.gov/PMC6925497 https://doaj.org/article/a9a78a15d77e4cc6a866beea415b84c2 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rixMxEA_nHRz3RXy7etYIgiCu7iObhyDS6h1HoYeohX4LSZrVg7LVdgveP-Tf6Uz2wS0efvDTQjOBNDOzM7Mz8xtCnksFZshzH7PS8ZiBzxxbaYrYgWtts8QVxmKj8Oycn83ZdFEs9kg33qq9wO21oR3Ok5pvVq9__bx8Dwr_Lii85G-2Kab7IChWMQKyxRDBH4BhEqinM9YnFTBU6BKb1247Iocg4eAgZGxgpQKY_9-v7Cs2a1hPecVAnd4iN1vPko4bUbhN9nx1hxzO2tz5XfK7gfenNjQu0HVJLRak19Qh4zfUVEtq6mYAFvZTUaw6p-08HnpR0VQVNIyWwOg6kNcI64goI377imKjCtCohNZrCgZfvKUQyu9W9bZZAk-TtkeY9Ef42OSHKJYzXoZd98j89OTrh7O4ndIQu0KldcydTFNvyyW38FSWK1sihj3EQb4srROZLwshlmLJfCbBX_Kp8qqUXomcGebz-2S_Wlf-IaESoqfEIeS-LVlqc5V4I11RutSKUiQ-IknHFe1aCHOcpLHSIZSRXDc81cBTjTzVSURe9lt-NPgd_yKeIKt7QoTeDj-sN990q8naKCOkSYulEJ45x40EqfbegCdkJXNZRJ6ioOimj7V_gegxR-xCxkQekReBAoUaju9M2wkBl4BgXAPK4wElqL4bLnfCqDvN0VnOMNvKJYvIs34Zd2I5XeXXO6TJsXkWwteIPGhkt__TnQpERAykenArw5Xq4nsAJucKPzeIR_-98zE5ylAf0yzO0mOyX292_gk4fbUdkRtiIUbkYDyefpnCc3Jy_unzKHxCGQU1_wNn1VgO |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEF_qFdQX8dtotSsoghiaTTbZXUGkZ1uutneItNC3NbvZaKEk9ZJD-g_56N_oTL5sEPrWp4Pb2WMvMzsfmZnfEPJKKjBDLnE-z23ic_CZfSPT2LfgWpswsHFqsFF4vkhmx_zzSXyyRv70vTBYVtnrxEZRZ6XFd-RbYcQxiZRI_vH8p49TozC72o_QaMXiwF38gpCt-rC_A_x9HYZ7u0efZn43VcC3sWK1n1jJmDN5lhj4VCZRJkfMdfDbXZ4bK0KXx0JkIuMulGDfHVNO5dIpEfGUuwh-9wZZ5xGEMhOyPt1dfPna636MRvrcKZPJVsUwEQnhuvIRKs4PRtavGRLwvym4ZAvHdZqXDN_eXXKn81jpditi98iaK-6Tm_MuJ_-A_G7HBlDTNETQMqcGC91ralGgljQtMprW7WAt7NOiWM1Ouzk_9LSgTMW0GVmBUXtDXiNcJKKXuOodxQYYoFEBrUsKjoR4T5euWp3VVbsEHiztjjAdjrDT5p0olkleNLsekuNr4dMjMinKwj0hVEJUFliE8jc5ZyZSgUuljXPLjMhF4DwS9FzRtoNGxwkdZ7oJkWSiW0ZqYKRGRurAI2-HLectLshVxFNk9UCIkN7NF-Xyu-40hE5VKmTK4kwIx61NUgm3xbkUPCwjuQ09somCotv-2EEx6e0EMRE5F5FH3jQUqJrg-DbtOizgISDI14hyY0QJKsWOl3th1J1Kq_S_C-iRl8My7sQyvcKVK6SJsCkXwmKPPG5ld_jTYDzA9w5htxhJ9eipjFeK0x8N4Hmi8DWGeHr1sTbJrdnR_FAf7i8OnpHbId46Fvoh2yCTerlyz8F7rM2L7spS8u26tcRfa8aB5w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+burden+of+breast+cancer+and+attributable+risk+factors+in+195+countries+and+territories%2C+from+1990+to+2017%3A+results+from+the+Global+Burden+of+Disease+Study+2017&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Li%2C+Na&rft.au=Deng%2C+Yujiao&rft.au=Zhou%2C+Linghui&rft.au=Tian%2C+Tian&rft.date=2019-12-21&rft.pub=BioMed+Central&rft.eissn=1756-8722&rft.volume=12&rft_id=info:doi/10.1186%2Fs13045-019-0828-0&rft_id=info%3Apmid%2F31864424&rft.externalDocID=PMC6925497 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon |